Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study
Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]
Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published
Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]
DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive
Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]
FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility
Neurology News Network for the week ending August 19, 2023. [WATCH TIME: 4 minutes]
Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders
Neurology News Network for the week ending August 12, 2023. [WATCH TIME: 3 minutes]
MS Medications Added to WHO Essential List, Epigenome Therapy Shows Efficacy in AD, Phase 3 NEURO-TTransform Results Announced
Neurology News Network for the week ending August 5, 2023. [WATCH TIME: 4 minutes]
Positive Data on Dravet Therapy STK-001, FDA Clears Zoom 88 LDP Support, MS Diagnostic Guidelines Updated
Neurology News Network for the week ending July 29, 2023. [WATCH TIME: 4 minutes]
TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced
Neurology News Network for the week ending July 22, 2023. [WATCH TIME: 3 minutes]
Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function
Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]
Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays
Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine
Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]
Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review
Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS
Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]
CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule
Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]
Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation
Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]
Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD
Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]
CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset
Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]
Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition
Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]
Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups
Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]
DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy
Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]
EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward
Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]
Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA
Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]
Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms
Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea
Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]
Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline
Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching
Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]
Gene Therapy ST-920 Shows Benefit in Fabry, Intermittent Calorie Restriction in Multiple Sclerosis, High Economic Burden Identified in NMOSD
Neurology News Network for the week ending March 4, 2023. [WATCH TIME: 3 minutes]
Sodium Oxybate Alters Sleep Structure, FDA Approves Deutetrabenazine, Associations of Stroke Decreased With Age
Neurology News Network for the week ending February 26, 2022. [WATCH TIME: 3 minutes]